ORANGE BELGIUM (OBEL.BR) Fundamental Analysis & Valuation

EBR:OBEL • BE0003735496

Current stock price

21 EUR
0 (0%)
Last:

This OBEL.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. OBEL.BR Profitability Analysis

1.1 Basic Checks

  • OBEL had positive earnings in the past year.
  • OBEL had a positive operating cash flow in the past year.
  • In the past 5 years OBEL has always been profitable.
  • OBEL had a positive operating cash flow in each of the past 5 years.
OBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFOBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.01%, OBEL is doing worse than 66.67% of the companies in the same industry.
  • OBEL's Return On Equity of 4.10% is fine compared to the rest of the industry. OBEL outperforms 66.67% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.65%, OBEL is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for OBEL is below the industry average of 6.17%.
  • The 3 year average ROIC (3.28%) for OBEL is below the current ROIC(3.65%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.01%
ROE 4.1%
ROIC 3.65%
ROA(3y)0.52%
ROA(5y)1.35%
ROE(3y)2.14%
ROE(5y)4.24%
ROIC(3y)3.28%
ROIC(5y)4.45%
OBEL.BR Yearly ROA, ROE, ROICOBEL.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • With a Profit Margin value of 2.10%, OBEL is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
  • In the last couple of years the Profit Margin of OBEL has declined.
  • OBEL has a Operating Margin of 7.80%. This is comparable to the rest of the industry: OBEL outperforms 50.00% of its industry peers.
  • In the last couple of years the Operating Margin of OBEL has grown nicely.
  • Looking at the Gross Margin, with a value of 67.92%, OBEL belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Gross Margin of OBEL has grown nicely.
Industry RankSector Rank
OM 7.8%
PM (TTM) 2.1%
GM 67.92%
OM growth 3Y-5.83%
OM growth 5Y6.3%
PM growth 3Y-20.46%
PM growth 5Y-12.51%
GM growth 3Y4.66%
GM growth 5Y2.94%
OBEL.BR Yearly Profit, Operating, Gross MarginsOBEL.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. OBEL.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OBEL is destroying value.
  • Compared to 1 year ago, OBEL has about the same amount of shares outstanding.
  • OBEL has more shares outstanding than it did 5 years ago.
  • OBEL has a better debt/assets ratio than last year.
OBEL.BR Yearly Shares OutstandingOBEL.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
OBEL.BR Yearly Total Debt VS Total AssetsOBEL.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 1.00, we must say that OBEL is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.00, OBEL is doing worse than 66.67% of the companies in the same industry.
  • OBEL has a debt to FCF ratio of 14.45. This is a negative value and a sign of low solvency as OBEL would need 14.45 years to pay back of all of its debts.
  • OBEL has a worse Debt to FCF ratio (14.45) than 83.33% of its industry peers.
  • A Debt/Equity ratio of 1.84 is on the high side and indicates that OBEL has dependencies on debt financing.
  • OBEL's Debt to Equity ratio of 1.84 is on the low side compared to the rest of the industry. OBEL is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.84
Debt/FCF 14.45
Altman-Z 1
ROIC/WACC0.71
WACC5.16%
OBEL.BR Yearly LT Debt VS Equity VS FCFOBEL.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 0.54 indicates that OBEL may have some problems paying its short term obligations.
  • OBEL has a worse Current ratio (0.54) than 83.33% of its industry peers.
  • A Quick Ratio of 0.50 indicates that OBEL may have some problems paying its short term obligations.
  • OBEL has a Quick ratio of 0.50. This is amonst the worse of the industry: OBEL underperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.5
OBEL.BR Yearly Current Assets VS Current LiabilitesOBEL.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. OBEL.BR Growth Analysis

3.1 Past

  • OBEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.71%, which is quite impressive.
  • OBEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.42% yearly.
  • OBEL shows a decrease in Revenue. In the last year, the revenue decreased by -1.52%.
  • The Revenue has been growing by 8.35% on average over the past years. This is quite good.
EPS 1Y (TTM)65.71%
EPS 3Y-14.2%
EPS 5Y-7.42%
EPS Q2Q%3.14%
Revenue 1Y (TTM)-1.52%
Revenue growth 3Y12.17%
Revenue growth 5Y8.35%
Sales Q2Q%-1.52%

3.2 Future

  • Based on estimates for the next years, OBEL will show a very strong growth in Earnings Per Share. The EPS will grow by 59.15% on average per year.
  • The Revenue is expected to grow by 3.06% on average over the next years.
EPS Next Y457.1%
EPS Next 2Y207.98%
EPS Next 3Y117.47%
EPS Next 5Y59.15%
Revenue Next Year1.24%
Revenue Next 2Y0.75%
Revenue Next 3Y3.52%
Revenue Next 5Y3.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OBEL.BR Yearly Revenue VS EstimatesOBEL.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
OBEL.BR Yearly EPS VS EstimatesOBEL.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

4

4. OBEL.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 34.43, which means the current valuation is very expensive for OBEL.
  • Based on the Price/Earnings ratio, OBEL is valued more expensive than 83.33% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.42. OBEL is valued slightly more expensive when compared to this.
  • Based on the Price/Forward Earnings ratio of 79.19, the valuation of OBEL can be described as expensive.
  • OBEL's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. OBEL is more expensive than 66.67% of the companies in the same industry.
  • OBEL is valuated expensively when we compare the Price/Forward Earnings ratio to 22.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 34.43
Fwd PE 79.19
OBEL.BR Price Earnings VS Forward Price EarningsOBEL.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OBEL indicates a rather cheap valuation: OBEL is cheaper than 83.33% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of OBEL indicates a somewhat cheap valuation: OBEL is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.8
EV/EBITDA 5.43
OBEL.BR Per share dataOBEL.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • OBEL has a very decent profitability rating, which may justify a higher PE ratio.
  • OBEL's earnings are expected to grow with 117.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y207.98%
EPS Next 3Y117.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OBEL.BR Dividend Analysis

5.1 Amount

  • No dividends for OBEL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OBEL.BR Fundamentals: All Metrics, Ratios and Statistics

ORANGE BELGIUM

EBR:OBEL (4/24/2026, 7:00:00 PM)

21

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)02-06
Earnings (Next)07-23
Inst Owners5.62%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.42B
Revenue(TTM)1.96B
Net Income(TTM)41.31M
Analysts46.67
Price Target19.89 (-5.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.31%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)26.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.12%
Valuation
Industry RankSector Rank
PE 34.43
Fwd PE 79.19
P/S 0.72
P/FCF 9.8
P/OCF 2.69
P/B 1.4
P/tB N/A
EV/EBITDA 5.43
EPS(TTM)0.61
EY2.9%
EPS(NY)0.27
Fwd EY1.26%
FCF(TTM)2.14
FCFY10.21%
OCF(TTM)7.8
OCFY37.13%
SpS29.13
BVpS14.96
TBVpS-8.25
PEG (NY)0.08
PEG (5Y)N/A
Graham Number14.3298 (-31.76%)
Profitability
Industry RankSector Rank
ROA 1.01%
ROE 4.1%
ROCE 4.86%
ROIC 3.65%
ROICexc 3.75%
ROICexgc 7.66%
OM 7.8%
PM (TTM) 2.1%
GM 67.92%
FCFM 7.36%
ROA(3y)0.52%
ROA(5y)1.35%
ROE(3y)2.14%
ROE(5y)4.24%
ROIC(3y)3.28%
ROIC(5y)4.45%
ROICexc(3y)3.34%
ROICexc(5y)4.59%
ROICexgc(3y)6.96%
ROICexgc(5y)10.01%
ROCE(3y)4.37%
ROCE(5y)6.1%
ROICexgc growth 3Y-28.53%
ROICexgc growth 5Y-5.72%
ROICexc growth 3Y-20.3%
ROICexc growth 5Y-9.74%
OM growth 3Y-5.83%
OM growth 5Y6.3%
PM growth 3Y-20.46%
PM growth 5Y-12.51%
GM growth 3Y4.66%
GM growth 5Y2.94%
F-Score6
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 1.84
Debt/FCF 14.45
Debt/EBITDA 2.94
Cap/Depr 79.95%
Cap/Sales 19.41%
Interest Coverage 1.71
Cash Conversion 83.47%
Profit Quality 349.83%
Current Ratio 0.54
Quick Ratio 0.5
Altman-Z 1
F-Score6
WACC5.16%
ROIC/WACC0.71
Cap/Depr(3y)97.25%
Cap/Depr(5y)123.66%
Cap/Sales(3y)22.67%
Cap/Sales(5y)28.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.71%
EPS 3Y-14.2%
EPS 5Y-7.42%
EPS Q2Q%3.14%
EPS Next Y457.1%
EPS Next 2Y207.98%
EPS Next 3Y117.47%
EPS Next 5Y59.15%
Revenue 1Y (TTM)-1.52%
Revenue growth 3Y12.17%
Revenue growth 5Y8.35%
Sales Q2Q%-1.52%
Revenue Next Year1.24%
Revenue Next 2Y0.75%
Revenue Next 3Y3.52%
Revenue Next 5Y3.06%
EBIT growth 1Y10.42%
EBIT growth 3Y5.62%
EBIT growth 5Y15.18%
EBIT Next Year211.78%
EBIT Next 3Y46.25%
EBIT Next 5Y32.21%
FCF growth 1Y35.39%
FCF growth 3YN/A
FCF growth 5Y-2.82%
OCF growth 1Y4.55%
OCF growth 3Y10.51%
OCF growth 5Y8.82%

ORANGE BELGIUM / OBEL.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ORANGE BELGIUM?

ChartMill assigns a fundamental rating of 3 / 10 to OBEL.BR.


What is the valuation status of ORANGE BELGIUM (OBEL.BR) stock?

ChartMill assigns a valuation rating of 4 / 10 to ORANGE BELGIUM (OBEL.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for ORANGE BELGIUM?

ORANGE BELGIUM (OBEL.BR) has a profitability rating of 5 / 10.


What are the PE and PB ratios of ORANGE BELGIUM (OBEL.BR) stock?

The Price/Earnings (PE) ratio for ORANGE BELGIUM (OBEL.BR) is 34.43 and the Price/Book (PB) ratio is 1.4.


How financially healthy is ORANGE BELGIUM?

The financial health rating of ORANGE BELGIUM (OBEL.BR) is 1 / 10.